EARNINGS REPORT by CSIMarket
Losses Widen but Revenues Unchanged
announced fiscal third quarter 2020 operating shortfall of $-0.056805 millions
![]() For the fiscal third quarter 2020 increased losses of $ -0.02 per share compare to $0.00 a year ago and from $0.00 per share from the previous quarter. Sales remained unchanged to $ 0 millions from $0 millions in the same quarter a year ago and sequentially from $0 millions. In the fiscal third quarter 2020 reported net loss of $ -0.057 million, instead of break-even in the same quarter a year ago.
|
Recently Reported Results |
Perdoceo Education Corp
Company reports $-69.05 million loss, as impairment charges strip off $0.61 million from the fiscal time frame ending Dec 31 2020 results.
from the preceding quarter from $0.56 per share, from $169.13 millions. In the fiscal year 2020, Perdoceo Education Corp reported Sales of $687.31 millions and net income of $124.26 millions. Eps soared by 79.38 % to $1.74 per share from $0.97 in the previous fiscal year, while Sales advanced by 9.5 % from $627.70 millions a year ago.
PRDO stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Industrial production
The industrial production growth rate accelerated compare to the slow down in previous month, due to increase in growing output at utilities.
|
Icon Plc
Icon Plc announced disappointing results, eps deteriorated by -9.43% to $6.15 from $6.79 and Sales declined by -0.3% to $2.80 billions in the financial time frame ending Dec 31 2020, year on year.
From the preceding quarter, from $0.00 per share and from $0.00 millions. In the fiscal year 2020, Icon Plc reported Sales of $2.80 billions and net income of $332.96 millions. Eps decreased by -9.43 % to $6.15 per share from $6.79 in the previous fiscal year, while Sales decreased by -0.3 % from $2.81 billions a year ago.
ICLR stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Sunesis Pharmaceuticals Inc
In the fourth quarter of 2020 Sunesis Pharmaceuticals Inc decreased loss of $-0.04 per share compared to $-0.05 a year ago and improved from $-0.29 per share from the previous quarter.
Sales remained unchanged to $0.00 millions from $2.07 millions in the same quarter a year ago and sequentially from $0.00 millions. Sunesis Pharmaceuticals Inc reported net loss of $-21.61 millions and Sales of $0.12 millions for the fiscal year 2020. Net loss per share has widen to $-1.53 from $-0.27 in previous fiscal year, while Sales decreased by -94.21 % from $2.07 millions a year ago.
SNSS stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Heidrick and Struggles International Inc
Company's earnings faded on asset impairments of $81.21 million in the fourth quarter of 2020
compared to the previous quarter eps fell from $0.44 per share and Sales Tumbled by -48.62% from $174.85 millions. Heidrick And Struggles International Inc reported net loss of $-37.71 millions and Sales of $629.37 millions for the fiscal year 2020. Company recorded loss per share of $-1.95 compared to $2.40 in the previous fiscal year, while Sales deteriorated by -13.26 % from $725.61 millions a year ago.
HSII stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Retail Inventories
|
Productivity
|
Personal Income and Spending
|
Williams Companies Inc
Williams Companies Inc announced disappointing results, eps deteriorated by -6.77% to $0.09 from $0.10 and Sales declined by -0.71% to $2.09 billions in the fourth quarter of 2020 earnings season, year on year.
From the preceding quarter, profit plummeted from $0.25 per share and Sales advanced by 8.23 % from $1.93 billions. In the fiscal year 2020, Williams Companies Inc reported Sales of $7.72 billions and net income of $198.00 millions. Eps dropped by -75.71 % to $0.17 per share from $0.70 in the previous fiscal year, while Sales decreased by -5.88 % from $8.20 billions a year ago.
WMB stock quotes, charts, profile
Growth Rates, Profitability, PE
|
U s Concrete Inc
Lower demand led to lower revenues and higher loss, in the fiscal fourth quarter of 2020 company slipped into loss to $-0.09 per share, while Sales fell by -9.43% to $334.40 millions, year on year.
In the previous quarter company realized Sales of $374.20 millions and bottom line of $1.42 per share. In the fiscal year 2020, U S Concrete Inc reported Sales of $1.37 billions and net income of $24.50 millions. Eps soared by 68.13 % to $1.53 per share from $0.91 in the previous fiscal year, while Sales deteriorated by -7.64 % from $1.48 billions a year ago.
USCR stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Booking Holdings Inc
In the fiscal time frame ending Dec 31 2020 Booking Holdings Inc slipped into loss of $-3.98 per share compared to $27.75 a year ago and eps fell from $19.49 per share from the previous quarter.
Sales fell sharply by -62.92% to $1.24 billions from $3.34 billions in the same quarter a year ago and sequentially Sales Tumbled by -53.11% from $2.64 billions. In the fiscal year 2020, Booking Holdings Inc reported Sales of $6.80 billions and net income of $59.00 millions. Eps dropped by -98.71 % to $1.44 per share from $111.82 in the previous fiscal year, while Sales Tumbled by -54.89 % from $15.07 billions a year ago.
BKNG stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Tc pipelines lp
In the fourth quarter of 2020 Tc Pipelines Lp income increased by 5.31 % of $1.00 per share compared to $0.95 a year ago and income per share increased by 11.41 % from $0.90 per share from the previous quarter.
Tc Pipelines Lp reported operating shortfall of $-49 millions, in the fourth quarter of 2020, a deterioration from the operating income of $107 millions, realized in fourth quarter of 2019 In the fiscal year 2020, Tc Pipelines Lp reported Sales of $0.00 millions and net income of $301.00 millions. Income improved by 4.28 % to $3.90 per share from $3.74 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.
TCP stock quotes, charts, profile
Growth Rates, Profitability, PE
|
United Therapeutics Corporation
United Therapeutics Corporation showed respectable growth in the financial period ending Dec 31 2020, where income surged by 81.75 % year on year to $2.18 per share and Sales increased by 23.72% to $384.90 millions.
Sequentially profit plummeted by -43.2% from $3.84 per share and Sales increased by 1.26 % from $380.10 millions. United Therapeutics Corporation reported earnings of $514.80 millions and Sales of $1.48 billions for the fiscal year 2020. Company reported earnings per share of $11.54 compared to $-2.39 in the previous fiscal year, while Sales increased by 2.38 % from $1.45 billions a year ago.
UTHR stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Encore Capital Group Inc
Encore Capital Group Inc reported declining eps on increasing revenue in the fourth quarter of 2020, where Sales grew by 4.01% to $382.61 millions in comparison to $367.85 millions on a year-over-year basis, while income fell by -15.25% to $1.16 per share, income per share was $1.37 in the same quarter a year ago.
In the previous quarter company realized Sales of $403.68 millions and bottom line of $1.72 per share. In the fiscal year 2020, Encore Capital Group Inc reported Sales of $1.50 billions and net income of $212.52 millions. Earnings per share grew by 25.33 % to $6.68 per share from $5.33 in the previous fiscal year, while Sales increased by 6.8 % from $1.41 billions a year ago.
ECPG stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
|
|
|
|
|